Upon binding to its ligands PD-L1 and PD-L2, that are expressed on antigen presenting cells and/or tumor cells [1], PD-1 recruits the phosphatases SHP1 and SHP2 which in turn suppresses T cell activation and function [2]. Here, PDCD1 is linked to neoplasm.